ASG Eye Hospital, one of India’s leading super-speciality eye care chains, has unveiled an ambitious long-term roadmap, ‘Vision 2030’, backed by an investment of ₹1,500–2,000 crore to dramatically expand access to quality ophthalmic care across the country. Supported by marquee investors General Atlantic and Kedaara Capital, the programme aims to grow ASG’s network from over 175 centres today to about 600–700 centres by 2030, with a sharp focus on under-served Tier 2 and Tier 3 cities.
The company plans a scale-led expansion model designed to address rising demand in India’s estimated USD 5.5 billion eye care market while tackling persistent gaps in specialist availability outside metros. Having already built a presence across 95+ cities with 175+ hospitals and 200 vision centres, ASG now intends to push deeper into “fringe” and district markets where patients often have to travel long distances for advanced eye care.
ASG’s Vision 2030 rests on a three-pillar growth engine combining acquisitions and organic expansion. The company plans 8–10 targeted niche practice acquisitions annually, building on its operating playbook from the integration of Vasan Eye Care, alongside 5–7 new state-of-the-art multispeciality centres each year. In addition, ASG will set up around 100 district-level centres annually to extend specialist services to rapidly growing districts where demand for eye care is high but clinical infrastructure remains limited.
“Vision 2030 is fundamentally about market disruption through impact. With over 80% of vision loss in India being preventable, our expansion is a mission to end unnecessary blindness. We are taking world class eye care out of the metropolitan hubs and into the heartland, where the need is more acute. Our significant investment is a declaration that no Indian should lose their sight due to lack of access or financial barriers. Through Public-Private partnerships and pioneering Tele-ophthalmology, we are building the infrastructure necessary to make quality eye care a right, not a privilege, for every citizen,” said Dr. Arun Singhvi, Managing Director and CEO, ASG Eye Hospital.
The investment blueprint goes beyond adding brick-and-mortar capacity and is closely tied to clinical excellence and operational standardisation across the network. By 2026, ASG plans to deploy capital and manpower into advanced surgical innovation, diagnostics, clinician training and research, supported by harmonised clinical protocols and digital workflows to ensure consistent standards of care.
A key element of the strategy is affordability through efficiency. By leveraging centralised procurement, technology and economies of scale, ASG aims to lower the cost of high-end procedures such as cataract, LASIK and retina surgeries, making advanced eye care more accessible without compromising clinical outcomes.
